Similar models of HCC monitoring that have outperformed GALAD include the HelioLiver test (methylated free cell DNA markers, AFP, AFP‐L3, DCP, age, and sex), which has also been validated in a clinical trial (NCT05059665) [91]. This evidence concerns the gene AFP and hepatocellular carcinoma.